Alway great to talk to Subodh Deshmukh, CEO of Aragen Bioscience, a CRO and CDMO specialising in biologics. Subodh shared insights on Aragen’s new production facility, the evolution into a full-scale CDMO, and how they ensure speed, quality, and affordability for clients.
TWENTYFOURSEVENBIOPHARMA